Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Rs 11000 crore benefit...

    Rs 11000 crore benefit to people from fixing drug prices: Minister

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-01-06T09:35:24+05:30  |  Updated On 6 Jan 2019 9:35 AM IST
    Rs 11000 crore benefit to people from fixing drug prices: Minister

    The Minister, who was replying during the Question Hour, said that to make medicines affordable, the government capped prices of 855 medicines and some medical devices.


    New Delhi: Fixing of medicine prices has resulted in Rs 11,000 crore benefit to people, Minister of State for Chemical and Fertilisers, Mansukh L Mandaviya told Rajya Sabha.


    The Minister, who was replying during the Question Hour, said that to make medicines affordable, the government capped prices of 855 medicines and some medical devices.


    He said the government has notified the Drug (Prices Control) Order (DPCO) to control and regulate the prices of medicines in the country.


    The prices of drugs are fixed by National Pharmaceutical Pricing Authority as per the provisions of DPCO and it does not distinguish between patented and non-patented drugs for fixing the ceiling prices of scheduled medicines, he said.


    Read Also: Steps to check High Drug Prices: Minister apprises Parliament

    affordable medicinesDPCOdrug pricesMansukh L MandaviyaMedical DevicesmedicinesNational Pharmaceutical Pricing AuthorityNew DelhiPharmaceuticalsRajya Sabha
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok